CD274 and esophageal squamous cell carcinoma: Studies have indicated that high expression of Siglec-15 in esophageal squamous carcinoma (ESCC) [76] and PC [77] contributes to tumor immune evasion within the TME, albeit without significant correlation with the PD-1/PD-L1 pathway (Fig. 1) [78].